Response To: Cost Effectiveness in the Prevention of VAP

Journal of the Intensive Care Society - United Kingdom
doi 10.1177/175114371401500422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

The Cost of Illness Attributable to Diabetic Foot and Cost-Effectiveness of Secondary Prevention in Peru

BMC Health Services Research
Health Policy
2015English

Modeling and Cost-Effectiveness in HIV Prevention

Current HIV/AIDS Reports
VirologyInfectious Diseases
2016English

845 Cost-Effectiveness Analysis in Fire Prevention

Injury Prevention
EnvironmentalPublic HealthOccupational Health
2016English

Pms49 - Cost-Effectiveness of Fracture Prevention Provided to Elderly Living in the Community

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Antiretroviral Therapy for Prevention

Current HIV Research
VirologyInfectious Diseases
2011English

Statin Cost Effectiveness in Primary Prevention: A Systematic Review of the Recent Cost-Effectiveness Literature in the United States

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Cost-Effectiveness of Expanded Newborn Screening in Texas—Author Response to Letter to the Editor

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy